In agreement, the blockade of AIM2 notably ameliorates SLE syndrome by reducing macrophage activation and dampening the inflammatory response in mice with apoptotic DNA-induced lupus [27]. The gene discussed is AIM2; the disease is systemic lupus erythematosus.